A slightly high thyroid number often needs watching, not a pill

Key takeaways

• In a 2017 trial of 737 adults age 65 and older with a mildly high TSH, a year of thyroid pills lowered the number but didn’t ease tiredness or symptoms compared with a dummy pill.
• A 2019 BMJ guideline panel advised against thyroid pills for most adults with a mildly high TSH, with exceptions for women trying to conceive and very high readings.
• Studies cited by the U.S. Preventive Services Task Force found that about 37% of mildly high results drifted back to normal without treatment over several years, so one test is rarely the final word.
• About 1.5 million Americans were prescribed animal-derived thyroid pills, usually made from pigs, in 2024; as of August 2026, the FDA called them unapproved but was enforcing case by case while it prepared draft guidance.
• Fever, a racing pulse, and signs affecting the brain or heart in someone with an overactive thyroid can signal thyroid storm, an emergency treated in intensive care; call 911.

In a trial published in 2017, 737 people age 65 and older shared one lab result. Their TSH, the brain’s signal to the thyroid, ran above normal, while their thyroid hormone stayed in range¹.

Half took levothyroxine, the standard thyroid pill, for a year. The other half took a dummy pill. To keep the secret, doctors even made fake dose changes for the placebo group¹.

The pill worked on paper. Average TSH fell to 3.63 on levothyroxine, compared with 5.48 on placebo¹. But on 100-point scales of thyroid symptoms and tiredness, the two groups ended the year less than half a point apart. The researchers had set 9 points as the smallest change a person would notice¹.

That result echoes a principle many natural-health readers live by: don’t medicate a body that may be fine.

Thyroid disease is still common and real. More than 12% of Americans, roughly 1 in 8 by our math, will develop a thyroid condition, and women are five to eight times more likely than men to have one². This article covers how the gland works, how to read the tests, and what the evidence says about popular choices.

Your thyroid takes orders from a thermostat in your brain

The thyroid in your neck makes two hormones, T4 and T3. Your body also converts T4 into T3, mainly in the liver and in tissues such as the brain³.

The pituitary gland in your brain keeps watch. When it senses too little T4, it releases more thyroid-stimulating hormone (TSH) to push the thyroid harder. When T4 climbs high enough, TSH output shuts down³.

That’s why the numbers run in opposite directions. A high TSH usually means a sluggish thyroid, and a low TSH usually means an overactive one³.

Iodine shortage is the top cause of an underactive thyroid worldwide but is rare in the U.S., and too much iodine can also cause trouble⁴. Our iodine article covers how much you need.

About 2% of Americans have a clearly underactive thyroid and up to 10% have the mild form, according to the American Thyroid Association (ATA). More than half of people with an underactive thyroid don’t know it⁴. Graves’ disease, the most common cause of an overactive gland in the U.S., affects about 1% of people²⁹.

Start with TSH. Most other thyroid tests answer narrower questions

The ATA calls TSH the best first test because it can shift before hormone levels go out of range³. A typical lab range runs from about 0.4 to 4.0⁴.

• Free T4 measures the hormone floating unattached in your blood, the part your cells can use. Paired with TSH, it gives a clearer picture than total T4, which rises with birth control pills or pregnancy³.
• T3 helps mostly with an overactive thyroid. In an underactive one, it’s the last number to fall, so a normal T3 doesn’t rule the problem out³.
• Antibody tests show what’s behind a thyroid problem. TPO and thyroglobulin antibodies point to Hashimoto’s disease, and TSI or TRAb antibodies point to Graves’³. Antibodies help with diagnosis but aren’t used to track treatment³.
• Reverse T3 is an inactive form. The ATA says it isn’t useful for diagnosing an underactive thyroid in people who aren’t hospitalized³.

TSH also shifts with age, illness and medicines, and its release varies so much that false alarms are common⁵. The normal range runs lower in pregnancy and higher in older people⁴. That’s why the ATA looks for a high reading on both a first and a repeat test⁴.

The ATA says low body temperature, saliva tests and thyroid ultrasound can’t diagnose an underactive thyroid⁴. And if you take biotin, the ATA advises skipping it for two days before a blood draw, since it can make thyroid tests look abnormal³. Our vitamins field guide explains why.

The thyroid test decoder

Our own guide, built from the sources cited. It explains common patterns but can’t diagnose you.

Result pattern	What it usually means	What guidelines suggest	Questions to ask
Normal TSH and free T4	In most healthy people, the thyroid is working3	No thyroid treatment; the Task Force takes no side on screening people without symptoms5	“If I still feel unwell, what else should we check?”
TSH mildly high (often 4 to 10), free T4 normal	Mild (subclinical) hypothyroidism4; many results return to normal5	Recheck; a BMJ panel advises against pills for most adults6	“Can we repeat this before deciding anything?”
TSH high, free T4 low	Underactive thyroid3	Levothyroxine, with TSH rechecked about 6 to 10 weeks after a dose change4	“What’s the cause, and when is my next test?”
TSH low, free T4 or T3 high	Overactive thyroid3	Antibody testing for Graves’; then drugs, radioactive iodine or surgery9	“What’s causing it, and which treatment fits me?”
TSH low, free T4 low	Occasionally a pituitary problem3	Further evaluation	“Should I see an endocrinologist?”
Positive TPO antibodies, TSH 2.5 to 4.0	Autoimmune thyroid activity34	Recheck TSH at least once a year4	“How often should I be retested?”
TSH above 4.0 while pregnant	Abnormal under the ATA’s 2017 pregnancy cutoff8	Treatment may help at this level, though evidence is limited8	“Does this change my care during pregnancy?”

A slightly high TSH often settles on its own

Doctors call a TSH that runs a little high, usually between 4 and 10, with normal T4, subclinical hypothyroidism. It causes few or no symptoms⁴.

The 2017 trial in the opening, known as TRUST, enrolled people averaging 74 years old, and none of its secondary measures improved on the pill¹.

A Swiss trial reported in 2020 checked the heart: in 185 adults over 65, 18 months of levothyroxine didn’t change how well it pumped⁷.

In 2019, a panel writing in The BMJ pooled 21 trials with 2,192 people. Thyroid pills made little or no difference to quality of life, symptoms, mood, tiredness or thinking⁶. The panel issued a strong recommendation against treating most adults with this result and advised monitoring instead⁶.

The panel’s advice doesn’t cover women trying to become pregnant, or anyone with a TSH above 20⁶. It may not fit people whose symptoms are severe, or adults about 30 or younger⁶. The panel also noted that other guidelines tend to treat once TSH tops 10, and sometimes lower⁶. The ATA says experts still disagree⁴.

In 2015, the U.S. Preventive Services Task Force called the evidence too thin to weigh the benefits and harms of testing adults without symptoms⁵. It warned of frequent false positives and much overdiagnosis, especially when TSH sits below 10⁵. Several studies it cited found that about 37 of every 100 people with a mildly high TSH drifted back to normal without treatment, usually over several years⁵.

The Task Force also noted that about a quarter of patients in earlier reviews were accidentally overtreated, which could raise risks to bones and the heart⁵. A 2024 check found no new evidence calling for an update⁵. Thyroid ultrasound screening has its own overdiagnosis story, told in our cancer screening article.

Pregnancy is the exception, and the evidence is still moving

Pregnancy gets different rules. An ATA commentary notes that the group’s 2017 pregnancy guidelines use a TSH of 4.0 as the cutoff for abnormal⁸.

Does treating a mild rise help? A 2024 analysis in the journal Thyroid pooled 5 trials of 763 women treated before pregnancy, all in fertility care, and 8 trials of 2,622 women treated in the first half of pregnancy⁸. Overall, levothyroxine didn’t improve live births, miscarriage or preterm birth⁸. Single studies hinted at a benefit for women with a TSH above 4.0 or several past miscarriages⁸.

If you already take thyroid medicine, your dose may need to rise by 30% to 50% in pregnancy, and the ATA advises testing when you plan a pregnancy or first learn you’re pregnant⁴. Tell your clinician early. Any dose change is theirs to make.

Hashimoto’s slows the gland, and Graves’ revs it up

Both are autoimmune diseases, but they push the thyroid in opposite directions.

Hashimoto’s disease is the most common autoimmune cause of an underactive thyroid⁴. Its signs, such as tiredness, feeling cold, dry skin, constipation, memory trouble, low mood and a weight gain of about 5 to 20 pounds, overlap with ordinary life, so blood tests are the only reliable check⁴. Treatment is a daily levothyroxine pill, usually for life, ideally from the same manufacturer each time⁴. Our medicine-spacing article explains why calcium and iron need distance from it.

In Graves’ disease, antibodies switch the whole gland on⁹. It’s the leading cause of an overactive thyroid in the U.S. and is seven to eight times more common in women⁹. Signs include a racing heartbeat, shaky hands, poor sleep, weight loss, weak muscles and feeling too hot⁹.

About one-third of people with Graves’ have some eye involvement, and about 5% develop moderate to severe eye inflammation; smoking makes it worse⁹. Treatment usually starts with a beta-blocker. Main options then include antithyroid pills such as methimazole, often taken for 12 to 18 months, radioactive iodine, or surgery⁹. Radioactive iodine and surgery almost always leave the gland underactive, which a daily pill then replaces⁹.

In a Swedish study of nearly 1,200 people with Graves’, hyperthyroidism resolved in 82% after radioactive iodine and 96% after surgery⁷. About 1 in 4 still didn’t feel fully recovered years later, often because of fatigue or eye problems⁷.

Pig thyroid pills: the FDA’s 2025 move and what trials show

Desiccated thyroid extract (DTE) is made from dried animal thyroid glands, usually from pigs, and sold under names such as Armour Thyroid and NP Thyroid¹⁰. It predates today’s drug approval process, so the FDA has never approved it¹². About 1.5 million Americans received prescriptions for it in 2024, compared with about 22 million for levothyroxine¹⁰. By our math, that’s about 1 in 16 people on these two kinds of thyroid pills.

In August 2025, the FDA sent letters telling makers it intended to take the products off the market, citing serious manufacturing violations, the ATA reported¹². The agency suggested patients work with their doctors to move to approved products over 12 months¹². Within a week, FDA Commissioner Marty Makary posted that the agency would pursue the first-ever approval of DTE, pending trial results, and in the meantime “ensure access”¹¹.

As of August 2026, the FDA still lists the pills as unapproved. It says even tablets from the same batch may not deliver the same hormone levels, and the products carry a higher risk of certain impurities¹⁰. It has told makers it plans draft guidance and, for now, applies risk-based enforcement, which lets it act against firms that fall short on quality¹⁰. The products also aren’t eligible for pharmacy compounding¹⁰.

The ATA doesn’t recommend DTE as a first choice. But in a September 2025 statement, it called DTE the right treatment for some patients and warned against leaving them without access during a long approval process¹².

In a 2013 crossover trial, 70 people with an underactive thyroid took DTE and levothyroxine in turn, without knowing which was which¹³. Symptom and psychological test scores came out the same, and both brought blood tests back to normal. Yet 49% preferred DTE, 19% preferred levothyroxine and 23% had no preference, and people lost a little more weight on DTE¹³.

The ATA’s patient booklet notes the trade-offs. Animal thyroid carries a different T4-to-T3 ratio than the human gland, potency can vary by batch, and allergic reactions have been reported⁴. Extra T3 can strain the heart⁴.

If you feel better on DTE, that experience counts, and one well-designed trial says you’re not alone. The open questions concern consistency and oversight, not whether a remedy from an animal gland can work. Any switch, in either direction, belongs in a planned conversation with your prescriber, with follow-up testing⁴¹⁰.

Thyroid “support” supplements are a separate issue, covered in our hormone-balancing article.

Selenium, gluten and other add-ons, rated

Selenium in Graves’ disease. In a German trial of 70 people starting methimazole, adding selenium didn’t help. After 24 weeks, 80% on selenium and 82% on placebo had normal hormone levels⁹. A commentator noted that Americans generally aren’t short on selenium⁹.

Selenium for mild Graves’ eye disease. In a trial of 159 people published in the New England Journal of Medicine in 2011, 61% improved on six months of selenium, compared with 36% on placebo. Only 7% worsened on selenium, versus 26% on placebo¹⁴. By our math, about 25 more people in every 100 improved. Our selenium article covers its use in Hashimoto’s.

Gluten. In a 2012 study, people with both Hashimoto’s and celiac disease needed higher levothyroxine doses than those with Hashimoto’s alone. When the celiac group went gluten-free on the same dose, TSH fell, a sign the pill was being absorbed better¹⁵. A commentator suggested considering celiac disease when someone needs an unusually large dose¹⁵. Our elimination-diet and ashwagandha articles cover more options.

Option	Evidence level	Why
Levothyroxine for a clearly underactive thyroid	Strong evidence	The ATA’s standard therapy, with doses set by TSH testing412
Thyroid pills for a mildly high TSH in most nonpregnant adults	Evidence says no, or unsafe	No symptom benefit across 21 trials; risk of overtreatment156
Desiccated thyroid for people who prefer it	Promising but early	One small crossover trial matched levothyroxine; batch consistency is the concern1013
Selenium added to Graves’ drug treatment	Evidence says no, or unsafe	No better response than placebo9
Selenium for mild Graves’ eye disease	Promising but early	One well-run trial of 159 people14
Gluten-free diet when celiac disease is present	Promising but early	Better pill absorption in a small study15
Gluten-free diet for Hashimoto’s without celiac disease	Not enough evidence	The study we found involved celiac disease15
Body temperature or saliva tests to diagnose a slow thyroid	Evidence says no, or unsafe	The ATA says they can’t diagnose it4

When to get help

Get emergency care for possible thyroid storm. This is the extreme form of an overactive thyroid. Its signs include fever, a racing pulse, brain and nervous-system problems, heart failure, and stomach or liver trouble⁷. It is treated in intensive care, so in the U.S., call 911. In a French study of ICU patients, 17% died in the unit despite treatment⁷. Triggers included stopping antithyroid medicine, infection and taking too much thyroid hormone⁷.

See a clinician soon if you have red, bulging or irritated eyes with Graves’, which calls for an eye doctor as well as your endocrinologist⁹. Ask for a TSH test if symptoms of a slow or fast thyroid are wearing on you³⁴. Planning a pregnancy with a thyroid condition is another reason to call early⁴.

Don’t change thyroid medicine on your own. The FDA advises people taking DTE to talk with their doctor¹⁰. Even a switch between brands of levothyroxine calls for a TSH recheck after 6 to 12 weeks⁴. If you suspect a thyroid product harmed you, report it to the FDA’s MedWatch program and keep the bottle.

Questions readers ask

The bottom line

Your thyroid runs on a feedback loop that usually corrects itself, and a single mildly high TSH is often a reason to recheck rather than to start a lifelong pill. Clear thyroid disease is different. Hashimoto’s, Graves’ and pregnancy all deserve prompt, tested care.

Natural and prescription options can both have a place: desiccated thyroid satisfies some patients, and selenium has narrow uses. Make any change with your clinician and a follow-up test, and treat signs of thyroid storm as an emergency.

Related reading

• Real hormone problems have names and tests, which “balance your hormones” claims lack
• Iodine Is Slipping in American Diets. Kelp Pills Are the Wrong Fix
• Selenium’s Safe Range Is Narrow. A 2008 Supplement Error Proved It
• Screening finds cancer early, and it also finds cancer that never mattered
• Steroid pills can quiet your own cortisol, which is why stopping suddenly is risky

Sources

1. Stott DJ, Rodondi N, Kearney PM, et al. “Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.” New England Journal of Medicine, 2017;376(26):2534-2544 (University of Bern repository record). boris.unibe.ch
2. American Thyroid Association. “Press Room.” Accessed October 2026. thyroid.org
3. American Thyroid Association. “Thyroid Function Tests.” Patient brochure, 2019. thyroid.org
4. American Thyroid Association. “Hypothyroidism.” Patient booklet, 2019. thyroid.org
5. U.S. Preventive Services Task Force. “Thyroid Dysfunction: Screening.” Final recommendation statement, March 24, 2015. uspreventiveservicestaskforce.org
6. Bekkering GE, Agoritsas T, Lytvyn L, et al. “Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline.” BMJ, 2019;365:l2006. pubmed.ncbi.nlm.nih.gov
7. American Thyroid Association. Clinical Thyroidology for the Public, Vol. 13, Issue 7, July 2020 (summaries of Bourcier S et al., “Thyroid storm in the ICU,” Crit Care Med; Sjölin et al., 2019; Gencer et al., 2020). thyroid.org
8. American Thyroid Association. Clinical Thyroidology for the Public, Vol. 17, Issue 7, July 2024 (summary of Sankoda A et al., Thyroid 2024, with commentary on the 2017 ATA pregnancy guidelines). thyroid.org
9. American Thyroid Association. Clinical Thyroidology for the Public, Vol. 11, Issue 7, July 2018 (summary of Kahaly GJ et al., J Clin Endocrinol Metab 2017, and the ATA Graves’ Disease brochure). thyroid.org
10. U.S. Food and Drug Administration. “FDA’s Actions to Address Unapproved Thyroid Medications.” Content current as of August 6, 2026. fda.gov
11. Lovelace B Jr. “FDA warns about unapproved thyroid pills, then says it’ll ‘ensure access’ to them.” NBC News (via NBC New York), August 14, 2025 (news report, cited for events only). nbcnewyork.com
12. American Thyroid Association. “American Thyroid Association Statement on Desiccated Thyroid Extract.” September 18, 2025. thyroid.org
13. American Thyroid Association. “Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism” (summary of Hoang TD et al., J Clin Endocrinol Metab 2013;98:1982-90). Clinical Thyroidology for the Public, Vol. 6, Issue 8, 2013. thyroid.org
14. American Thyroid Association. “Selenium and mild Graves’ eye disease” (summary of Marcocci C et al., N Engl J Med 2011;364:1920-31). Clinical Thyroidology for Patients, Vol. 4, Issue 8, August 2011. thyroid.org
15. American Thyroid Association. “The effect of celiac disease on the absorption of levothyroxine tablets” (summary of Virili C et al., J Clin Endocrinol Metab 2012). Clinical Thyroidology for Patients, Vol. 5, Issue 6, 2012. thyroid.org